Introduction {#sec1}
============

The human SLX1-SLX4 structure-selective endonuclease plays a key role in DNA repair, homologous recombination, replication fork restart, and telomere maintenance ([@bib40]). The genes encoding *Saccharomyces cerevisiae* Slx1 and Slx4 were discovered in a genetic screen for mutations that are synthetic lethal in the absence of the Sgs1 helicase, a protein that is important for genome stability ([@bib31]). Homology searches subsequently identified the *SLX1* and *SLX4* genes in higher eukaryotes ([@bib2; @bib17; @bib32; @bib41]). Slx1 is an evolutionarily conserved protein that contains an N-terminal GIY-YIG nuclease domain (also called URI domain) and a C-terminal zinc-finger domain. GIY-YIG domains also are present in homing nucleases, the bacterial nucleotide excision-repair nuclease UvrC, and several type II restriction enzymes ([@bib15]). The mechanism of substrate binding and cleavage for GIY-YIG family members has been elucidated by crystallographic studies of protein-DNA complexes obtained for two restrictases, namely R.Eco29kl ([@bib27]) and Hpy188I ([@bib36]).

The Slx4 subunit of the Slx1-Slx4 nuclease is thought to provide a scaffold that coordinates the actions of a number of proteins involved in DNA processing ([@bib14]). For example, vertebrate SLX4 is a large, multi-domain protein that interacts with several DNA repair proteins ([@bib2; @bib17; @bib32; @bib33; @bib41]): (1) the N-terminal region of human SLX4 binds the MSH2-MSH3 mismatch-repair complex and XPF-ERCC1 nucleotide excision-repair enzyme; and (2) the C-terminal portion of SLX4 binds the telomeric proteins TRF2 and RAP1, the PLK1 kinase, and the MUS81-EME1 endonuclease. In all organisms studied to date, SLX1 binds to the extreme C-terminal region of SLX4, which contains an evolutionarily conserved helix-turn-helix motif. Interestingly, in vitro studies have shown that SLX4 stimulates the endonuclease activities of SLX1, MUS81-EME1, and XPF-ERCC1 ([@bib22; @bib32; @bib44]). The importance of SLX4 is demonstrated by the observation that biallelic mutations in SLX4 (also known as FANCP) are associated with the cancer-prone disorder Fanconi anemia ([@bib7; @bib25; @bib37]).

Although the amino acid sequence of SLX4 is evolutionarily diverse, the C-terminal region of all SLX4 proteins contains a conserved C-terminal domain (CCD) that underpins the interaction with SLX1 and a DNA-binding SAP domain found in many DNA repair proteins ([@bib2; @bib4; @bib17; @bib32; @bib41]). In yeast, there are few other discernible domains, whereas SLX4 proteins from higher eukaryotes (e.g., worms, flies, and humans) contain one or two copies of a UBZ family zinc-finger domain known as UBZ4; the MEI9^XPF^ interaction like region (MLR); and a Broad-complex, Tramtrack, and Bric-a-brac (BTB) domain ([@bib38]).

The role of SLX1-SLX4 in DNA repair has been studied extensively ([@bib14; @bib34; @bib43]). Although deletion of Slx1 in yeast does not affect the response to DNA damage, it has been shown that Slx1-Slx4 plays a role in maintaining the integrity of ribosomal loci, which contain tandem repeats that frequently lead to replication fork arrest ([@bib12]). It is possible that Slx1-Slx4 is involved in the collapse of stalled forks and the resolution of recombination intermediates, such as Holliday junctions (HJs), after fork recapture ([@bib21]). In human cells, transient depletion of SLX4 leads to an increased sensitivity to alkylating and crosslinking agents, indicating the importance of SLX4 for the repair of DNA inter-strand crosslinks (ICLs) and protein-DNA adducts. Depletion of SLX4 also reduces the efficiency of double-strand break repair and leads to genome instability ([@bib19; @bib32; @bib35; @bib41; @bib42]). Collectively, these observations indicate that SLX1 and/or SLX4 have relatively well-conserved roles in processing DNA intermediates that arise at stalled or collapsed replication forks, particularly when cells are treated with DNA-damaging agents that interfere with normal replication fork progression.

Purified *S. cerevisiae* Slx1-Slx4 cleaves various DNA substrates in vitro, including splayed-arm structures, model replication forks, 5′-flaps, and HJs ([@bib18]). For the 5′-flap substrates, the major cleavage site lies in the 5′ single-stranded arm at the junction between single- and double-stranded DNA. Whereas Slx1 alone possesses weak nuclease activity, the rate is stimulated approximately 500-fold by Slx4. Purified human SLX1-SLX4 exhibits related activities and cleaves 5′-flaps, 3′-flaps, replication forks, and HJs. Of particular interest, SLX1-SLX4 and MUS81-EME1 cooperate during HJ resolution, with SLX1-SLX4 performing the initial nick such that MUS81-EME1 can resolve the nicked HJ without substrate dissociation ([@bib44]).

Although there is a significant amount of functional information available for Slx1-Slx4 and its associated proteins, structural and mechanistic insights for this enzyme are lacking. Here we report the crystal structure of the Slx1 nuclease, obtained using *Candida glabrata* Slx1 (*Cg*-Slx1). The protein forms a compact structure with the GIY-YIG nuclease and RING-finger domains interacting with each other, and the structural arrangement is reinforced by a long α helix. We find that *Cg*-Slx1 forms a stable homodimer in the absence of *Cg*-Slx4. Importantly, the crystal structure of *Cg*-Slx1 in complex with *Cg*-Slx4^CCD^, together with biochemical analyses, demonstrate that *Cg*-Slx1 homodimerization is mutually exclusive with the formation of a *Cg*-Slx1-Slx4^CCD^ heterodimer, revealing a likely regulatory mechanism for Slx1 endonuclease activity.

Results and Discussion {#sec2}
======================

Overall Structure of *Cg*-Slx1 {#sec2.1}
------------------------------

To obtain structural information for Slx1, we purified *C. glabrata* Slx1 protein (*Cg*-Slx1) alone and in complex with the conserved C-terminal domain of Slx4 (*Cg*-Slx1-Slx4^CCD^). When the enzymatic activities of *Cg*-Slx1 and *Cg*-Slx1-Slx4^CCD^ were verified using synthetic DNA substrates (for sequences, see [Figures S1](#app3){ref-type="sec"}A and S1B), we found that *Cg*-Slx1 exhibited little or no activity, whereas the *Cg*-Slx1-Slx4^CCD^ complex cleaved a diverse set of branched DNA structures ([Figure 1](#fig1){ref-type="fig"}). The observed nuclease activity was inherent to Slx1, as substitution of an invariant residue in the active site (Slx1^E79Q^) abolished the nuclease activity of *Cg*-Slx1-Slx4^CCD^ ([Figure 1](#fig1){ref-type="fig"}B, bottom). We observed that the HJ was the preferred substrate for *Cg*-Slx1-Slx4^CCD^, followed by 5′-flap, splayed arm, and 3′-flap DNA structures ([Figures 1](#fig1){ref-type="fig"}B \[top\] and 1C). In contrast, the enzyme failed to cleave gapped, nicked, and double- or single-stranded DNA substrates. A similar substrate preference was reported for full-length yeast ([@bib18]) and human ([@bib44]) enzymes, although *Cg*-Slx1-Slx4^CCD^ was comparatively more active on 3′-flaps. Enzyme titration experiments with the 5′-flap substrate revealed that the primary cleavage product, a nicked or gapped DNA duplex, was processed further to generate a shorter DNA duplex ([Figure 1](#fig1){ref-type="fig"}A). However, time-course experiments carried out with limiting amounts of protein revealed that the major reaction was a single nick that converted the 5′-flap into a linear duplex ([Figure 1](#fig1){ref-type="fig"}B). This is consistent with the inability of *Cg*-Slx1-Slx4^CCD^ to cleave nicked or gapped DNA duplexes when protein is limiting. To gain more insight into the mechanism by which *Cg*-Slx1-Slx4^CCD^ cleaves 5′-flaps, we prepared two different substrates, each ^32^P-labeled on a different oligonucleotide ([Figures S1](#app3){ref-type="sec"}C and S1D). Time-course experiments revealed two independent cleavage sites: a primary incision that removed the 5′-flap, and a less efficient incision reaction that removed the duplex arm. Collectively, our results provide additional evidence for the promiscuous nature of Slx1-Slx4, suggesting that this biochemical property has been conserved throughout evolution.

We next obtained crystals of *Cg*-Slx1^E79Q^, which belonged to the *P*4~3~2~1~2 space group, and diffracted X-rays to 2.34 Å resolution. The protein was predicted to contain a zinc finger, so diffraction data were collected at the zinc absorbance peak wavelength (1.280 Å), and the structure was solved by zinc single-wavelength anomalous diffraction (SAD) ([Table S1](#app3){ref-type="sec"}). The asymmetric unit of the crystal contained one Slx1 molecule and the structure was refined to an *R*~free~ of 25.1% ([Table S1](#app3){ref-type="sec"}). Fragments of simulated annealing composite omit electron density maps are presented in [Figure S2](#app3){ref-type="sec"}A. We noted that the loop regions of the zinc-finger domain had higher B factors and less-well-defined electron density maps, indicating the flexibility of this part of the structure.

The *Cg*-Slx1 monomer consists of two distinct domains: (1) an N-terminal GIY-YIG or URI nuclease domain, and (2) a C-terminal zinc-finger domain. In the *Cg*-Slx1 structure, these two domains interact with each other and form an oblong molecule approximately 70 Å long and 30--40 Å wide ([Figure 2](#fig2){ref-type="fig"}). The overall structure is reinforced by a long α helix (helix α6, located between the two domains and comprising residues 176--214) that spans the entire molecule and provides a scaffold for the two domains. The central element of the nuclease domain is a β sheet consisting of five strands arranged β2-β1-β3-β6-β7 (numbered in the amino acid sequence, [Figure S2](#app3){ref-type="sec"}C), with strands β2 and β3 oriented antiparallel to β1, β6, and β7 ([Figure 2](#fig2){ref-type="fig"}). The β sheet is flanked by six helices; short helix α1 and long helix α6 are located on one side of the sheet and four helices (α2--α5) are positioned on the other side. The α2--α5 region also contains a β hairpin formed by strands β4 and β5 ([Figure 2](#fig2){ref-type="fig"}). Comparisons of *Cg*-Slx1 structure with related GIY-YIG nucleases can be found in the [Supplemental Results](#app3){ref-type="sec"} and in [Figures S2](#app3){ref-type="sec"}D--S2G. The active site of *Cg*-Slx1 is highly conserved with other GIY-YIG nucleases ([Figure S2](#app3){ref-type="sec"}H), and we therefore propose that the catalytic mechanism of Slx1 is identical to that described for Hpy188I ([@bib36]). Details of the organization of the active site and the catalytic mechanism proposed for *Cg*-Slx1 can be found in the [Supplemental Results](#app3){ref-type="sec"} and in [Figures S2](#app3){ref-type="sec"}H and S2I. The C-terminal part of the *Cg*-Slx1 structure comprises a zinc-finger domain. Our structure shows that it is a RING finger closely related to domains found in ubiquitin ligases ([Supplemental Results](#app3){ref-type="sec"}; [Figures S2](#app3){ref-type="sec"}J--S2L).

Slx1 Dimerization {#sec2.2}
-----------------

Inspection of the *Cg*-Slx1 crystal packing revealed that a 2-fold crystallographic axis generated a very tight protein dimer, with a total buried surface area of 4,729 Å^2^ ([Figure 3](#fig3){ref-type="fig"}A). At the dimer interface, helix α2 of one monomer was positioned snugly in a groove located between the nuclease and RING domains of the other subunit. Notably, the side chain of Arg72, found at the N terminus of helix α2, was inserted into a pocket on the surface of the other subunit, where it interacted with the backbone carbonyls of Glu3 and Gln5. Another prominent interaction that stabilized the homodimer involved Tyr86 from the Slx1-specific β4-β5 hairpin of one subunit and helix α7 from the RING domain of the other subunit. Contacts were also made between Glu121, Tyr122, and Tyr86 from one subunit and Thr271, Ile272, and Ile273 of the other. Together, these residues formed a network of charged and van der Waals interactions through their side chains. Two symmetrical copies of this part of the interface were located close to each other and formed a continuous zipper of interdigitated amino acid side chains ([Figure 3](#fig3){ref-type="fig"}B).

The extensive dimerization contacts and large buried surface area prompted us to investigate whether *Cg*-Slx1 dimerization occurs in solution. To do this, we used gel filtration coupled to multi-angle light scattering (GF-MALS) ([Figure 3](#fig3){ref-type="fig"}C) and analytical ultracentrifugation (AUC) ([Figure S3](#app3){ref-type="sec"}A). The molecular weight (MW) of *Cg*-Slx1 measured by GF-MALS was 80.3 kDa and 72.0 kDa by AUC, suggesting that *Cg*-Slx1 exists as a homodimer in solution (calculated MW of 72.0 kDa). We subsequently investigated the multimeric state of the *Cg*-Slx1-Slx4^CCD^ complex. First, we used GF-MALS to determine that the MW of *Cg*-Slx4^CCD^ alone was 19.0 kDa. This is in agreement with the theoretical MW of 19.7 kDa and indicates that *Cg*-Slx4^CCD^ is monomeric in solution. For *Cg*-Slx1-Slx4^CCD^, the measured MW was 57.0 kDa (GF-MALS) and 47.0 kDa (AUC). Importantly, these data indicate that the *Cg*-Slx1-Slx4^CCD^ complex contains one molecule of Slx1 and one molecule of Slx4^CCD^ (calculated MW of 57.0 kDa). Our results therefore demonstrate that *Cg*-Slx1 alone exists as a stable homodimer, but, in the presence of *Cg*-Slx4^CCD^, interacts with this subunit to form a stable heterodimeric complex. Close inspection of the *Cg*-Slx1 homodimeric structure showed that the active site of each subunit was partially blocked by the RING domain of the other subunit ([Figures 3](#fig3){ref-type="fig"}A and [S4](#app3){ref-type="sec"}). This suggests that dimerization blocks the activity of *Cg*-Slx1. Indeed, *Cg*-Slx1 ([Figure 1](#fig1){ref-type="fig"}A) as well as the *S. cerevisiae* ([@bib18]) and human ([@bib32]) enzymes are inactive in the absence of Slx4.

To gain further insight into the *Cg*-Slx1 homodimerization, we prepared a series of *Cg*-Slx1 variants with substitutions in dimer interface residues. These protein variants were structurally unstable ([Supplemental Results](#app3){ref-type="sec"}; [Figures S3](#app3){ref-type="sec"}A--S3C). Additional gel filtration experiments demonstrated that *Cg*-Slx1 homodimerization and *Cg*-Slx1-Slx4^CCD^ complex formation are mutually exclusive, and the exchange between the two forms can be promoted by high salt concentration ([Supplemental Results](#app3){ref-type="sec"}; [Figures S3](#app3){ref-type="sec"}D and S3E).

In summary, our results show that *Cg*-Slx1 is a homodimer in solution. Furthermore, they indicate that *Cg*-Slx1 dimerization provides a physical block to the active site. Thus, these findings provide a potential mechanism by which Slx1 nuclease activity is inhibited.

A Model for DNA Substrate Binding {#sec2.3}
---------------------------------

The *Cg*-Slx1 structure presented here does not contain a DNA substrate. Nonetheless, *Cg*-Slx1-DNA interactions can be modeled based on the conservation of the active site between Slx1 and GIY-YIG restrictases, for which high-resolution protein-DNA structures are available. To this end, we superimposed the Eco29kI structures (Protein Data Bank \[PDB\] ID [3NIC](pdb:3NIC){#intref0010} \[[@bib27]\]) on our *Cg*-Slx1 structure, which resulted in a good fit between DNA from the Eco29kI structures and the surface of Slx1. The modeling revealed that *Cg*-Slx1 contains two groups of potential DNA-binding residues, all but one of which are located in the nuclease domain ([Figure 4](#fig4){ref-type="fig"}A). The first group (Arg35, Arg38, Gln39, and Gln191) could interact with the non-cleaved DNA strand toward its 5′ end from the active site. Based on the polarity of the DNA at the active site, these residues are predicted to contact regions of flap and splayed arm substrates that contain only double-stranded DNA ([Figure 4](#fig4){ref-type="fig"}B). Arg35, Arg38, and Gln39 were all located in the vicinity of the phosphate groups of the modeled DNA. Sequence alignment of fungal Slx1 proteins revealed that Arg35 and Gln39 are strictly conserved and Arg38 is partially conserved ([Figure S2](#app3){ref-type="sec"}C). Non-conserved Gln191 was also located in this region but was positioned farther from the substrate in our *Cg*-Slx1-DNA model.

The second group of predicted DNA-binding residues (Arg72, Gln77, His80, and His84) was located on the opposite face of the active site relative to the first group. These residues are predicted to contact the 5′ region of the cleaved strand that exists as single-stranded DNA in flap and splayed arm substrates. In the Eco29kl-DNA structure, the straight DNA duplex extended farther away from these residues, suggesting that the single-stranded portion of the splayed arm or 5′-flap substrates must be bent to interact with the protein. Gln77, His80, and His84 were all located in helix α2 very close to the metal-coordinating active site residue Glu79. Among fungal Slx1 proteins, Gln77 is conserved and, in some species, replaced with a lysine. Notably, His80 and His84 are less conserved. Although His80 is substituted by a tryptophan in most species, His84 is always replaced with a charged residue. Interestingly, both Arg72 and the region around His80 are buried in the *Cg*-Slx1 homodimer, which likely contributes to its inhibition ([Figure S4](#app3){ref-type="sec"}A).

To verify the importance of the potential DNA-binding residues identified in our model, we prepared several *Cg*-Slx1 variants in which these residues were individually substituted with alanine. The *Cg*-Slx1 mutants were purified in the context of the *Cg*-Slx1-Slx4^CCD^ complex and enzyme activity was determined using the 5′-flap substrate ([Figure 4](#fig4){ref-type="fig"}C). These mutants showed either a complete loss of nuclease activity (R35A and Q39A) or substantially impaired activity (R38A, R72A, Q77A, Q191A, H80, and H84). We also tested the ability of these Slx1 variants to bind the 5′-flap substrate using electrophoretic mobility shift assays (EMSAs) ([Figure 4](#fig4){ref-type="fig"}D). *Cg*-Slx1 alone did not exhibit DNA-binding properties, while *Cg*-Slx1-Slx4^CCD^ formed a protein-DNA complex with reduced mobility. At high protein concentrations, two protein-DNA complexes were observed, possibly indicating the binding of two Slx1 molecules to DNA. The R38A and Q39A mutants showed slightly stronger substrate binding compared to the wild-type protein, despite exhibiting severe catalytic defects. Importantly, Arg38 and Gln39 are located close to the active site and Gln39 forms a hydrogen bond with active site residue Arg36. Therefore, Arg38 and Gln39 likely participate in active site stabilization upon DNA binding. The R72A variant displayed nearly wild-type binding affinity for the substrate. Its greatly reduced activity suggests that Arg72, which is located in the vicinity of the scissile phosphate, has a more important role in aligning the substrate for cleavage than enhancing substrate affinity. The remaining mutants, namely R35A, Q77A, H80A, H84A, and Q191A, all displayed defects in DNA binding. Interestingly, the most severe defects were observed with the H84A variant. His84 is located in helix α2, which we postulate to participate in binding the single-stranded portion of the 5′-flap DNA. This result further underscores the importance of helix α2 in the DNA-binding interface.

Collectively, the biochemical results support our proposed model of Slx1-DNA interactions. We have therefore identified two regions of *Cg*-Slx1 that are important for protein-DNA interactions: (1) one predicted to bind double-stranded portion of the DNA, and (2) the other potentially interacting with the single-stranded flap.

Slx1-Slx4^CCD3^ Complex Structure {#sec2.4}
---------------------------------

Our initial crystallization trials with *Cg*-Slx1-Slx4^CCD^ did not yield any crystals, so to gain further insight into *Cg*-Slx1-Slx4 interaction, we performed additional deletion studies. Based on bioinformatic predictions and limited proteolysis experiments, we designed four truncated forms of Slx4^CCD^, comprising residues 557--685 (*Cg*-Slx4^CCD1^), 608--685 (*Cg*-Slx4^CCD1A^), 557--698 (Cg-Slx4^CCD2^), or 647--726 (*Cg*-Slx4^CCD3^) ([Figure S5](#app3){ref-type="sec"}A). All of these fragments were soluble when expressed in *Escherichia coli* ([Figure S5](#app3){ref-type="sec"}B), but only the CCD3 variant co-purified with *Cg*-Slx1 ([Figures S5](#app3){ref-type="sec"}C and S5D). When we analyzed the activity of *Cg*-Slx1-Slx4^CCD3^ on the 5′-flap DNA, we found that it displayed slightly less activity than *Cg*-Slx1-Slx4^CCD^ and that the cleavage sites for both CCD variants were similar ([Figure S5](#app3){ref-type="sec"}E).

We subsequently obtained crystals of the *Cg*-Slx1-Slx4^CCD3^ complex. They belonged to the *P*6~3~ space group and diffracted X-rays to 1.8 Å ([Table S1](#app3){ref-type="sec"}). The structure was solved by molecular replacement using the *Cg*-Slx1 model and the structure of *Cg*-Slx4^CCD3^ was traced manually ([Figures 5](#fig5){ref-type="fig"} and [S2](#app3){ref-type="sec"}B). The overall conformation of *Cg*-Slx1 domains did not change significantly upon Slx4 binding, although the location of the RING domain changed slightly ([Figures S5](#app3){ref-type="sec"}F and S5G). When *Cg*-Slx1 and *Cg*-Slx1-Slx4^CCD3^ were superimposed using the GIY-YIG domains, the position of the RING domain residues differed by up to ∼3.5 Å. The β4-β5 hairpin was not formed in the *Cg*-Slx1-Slx4^CCD3^ complex and this part of the structure adopted a different conformation ([Figure 5](#fig5){ref-type="fig"}A). This suggests that the hairpin was stabilized by *Cg*-Slx1 homodimerization.

The structure of *Cg*-Slx4^CCD3^ comprises five α helices. Its closest structural homologs are FF domains mediating protein-protein interactions ([@bib5]). For example, Prp40 FF1 domain (PDB ID [2B7E](pdb:2B7E){#intref0015} \[[@bib20]\]) can be superimposed on *Cg*-Slx4^CCD3^ with an rmsd of 1.6 Å over 37 Cα atoms. Notably, however, the characteristic phenylalanine residues of the FF domain are not conserved in *Cg*-Slx4. *Cg*-Slx4^CCD3^ was positioned in a cleft between the nuclease and RING domains, and most of the interactions between the *Cg*-Slx1 and *Cg*-Slx4^CCD3^ occurred through hydrophobic contacts ([Figure 5](#fig5){ref-type="fig"}B). In particular, the second short α helix of *Cg*-Slx4^CCD3^ was placed snugly in a hydrophobic groove on the *Cg*-Slx1 surface. The groove lined up with the side chains of *Cg*-Slx1 Phe4 (nuclease domain) and Tyr257, Ile292, and Ile273 (RING domain). The side chain of *Cg*-Slx4 Phe681, which is conserved in most fungal Slx4 sequences ([Figure S5](#app3){ref-type="sec"}A) and is located in the second short α helix, was inserted into a pocket on the *Cg*-Slx1 surface. The hydrophobic interactions were reinforced further by stacking of *Cg*-Slx1 Tyr257 with *Cg*-Slx4 Tyr679. In addition, the backbone carbonyl of this tyrosine formed a hydrogen bond with the Nε1 of the conserved Trp288 in *Cg*-Slx1. Additional residues at the *Cg*-Slx1-Slx4 interface included *Cg*-Slx1 Ile73, Tyr122, and Tyr125, all of which interacted with the C terminus of the last α helix of *Cg*-Slx4^CCD3^ and the following loop (residues 714--720). The importance of the latter interaction was confirmed by the lack of binding between *Cg*-Slx1 and Slx4^CCD2^, in which the C-terminal helix of the CCD is absent.

In murine SLX4, the C1536R mutation abolished its interaction with SLX1 ([@bib9]). This cysteine corresponds to *Cg*-Slx4 Gly716 located at the C terminus of the last helix of *Cg*-Slx4^CCD3^. Insertion in this position of an arginine residue with a large side chain would lead to steric clashes with *Cg*-Slx1, explaining the effect of C1536R mutation. This observation further validates the interactions identified in our *Cg*-Slx1-Slx4^CCD3^ structure. Importantly, the position of *Cg*-Slx4^CCD3^ in the Slx1-Slx4 heterodimer overlapped with the position of one of the Slx1 monomers in the *Cg*-Slx1 homodimer ([Figures S5](#app3){ref-type="sec"}F and S5G). In fact, several residues, including *Cg*-Slx1 Tyr122 and Ile273, participated in both *Cg*-Slx1 homodimerization and *Cg*-Slx1-Slx4 heterodimerization, thus explaining why the formation of *Cg*-Slx1 homodimeric and *Cg*-Slx1-Slx4^CCD^ heterodimeric complexes are mutually exclusive events. Slx4^CCD3^ was located away from the predicted DNA-binding interface of *Cg*-Slx1 and is not expected to form contacts with the substrate ([Figure S4](#app3){ref-type="sec"}B).

In conclusion, the studies presented here provide the first structural information for Slx1 and its interaction with Slx4. Structure-selective endonucleases pose an inherent threat to genome integrity because broken DNA ends can facilitate chromosome rearrangements and genome alterations that are potentially tumorigenic. It is therefore crucial to keep these endonucleases tightly regulated to ensure cleavage of the correct DNA substrate at an appropriate time in the cell cycle. Recent studies have revealed that these regulatory mechanisms operate at various levels: protein expression ([@bib13]), post-translation modification (Mus81-Eme1/Mms4, Yen1) ([@bib6; @bib28; @bib29]), nuclear localization (GEN1) ([@bib10]), conformational changes (FEN1) ([@bib24; @bib39]), and protein-protein interactions (e.g., XPG, XPF-ERCC1, and SLX-MUS) ([@bib3; @bib26; @bib44; @bib45]). Our data suggest a mechanism of Slx1 regulation through inhibitory homodimerization that would keep Slx1, a promiscuous and potentially dangerous endonuclease, latent and ensure that its activity is tightly regulated in cells.

Experimental Procedures {#sec3}
=======================

Crystallization {#sec3.1}
---------------

Purified *Cg*-Slx1, at a concentration of 10 mg/ml, was subjected to crystallization screens at 18°C using the sitting-drop vapor diffusion method. Prior to crystallization, the protein was dialyzed against buffer containing 20 mM HEPES-NaOH (pH 7.5), 350 mM NaCl, and 1 mM DTT. Crystals were obtained with 1.4 M sodium citrate tribasic dihydrate and 0.1 M HEPES-NaOH (pH 7.5). Crystals were cryoprotected using 30% glycerol (v/v) before data collection. Purified *Cg*-Slx1-Slx4^CCD3^, at a concentration of 10 mg/ml, was subjected to crystallization screens at room temperature using the sitting-drop vapor diffusion method. Prior to crystallization, the protein was dialyzed against buffer containing 20 mM HEPES-NaOH (pH 7.5), 150 mM NaCl, and 1 mM DTT. Crystals were obtained with 0.2 M magnesium chloride hexahydrate, 0.1 M Bis Tris (pH 6.5), and 25% (v/v) PEG 3350 in the presence of a splayed arm DNA substrate with 15-bp double-stranded portion and 5-nt single-stranded overhangs. Crystals were cryoprotected using 30% glycerol (v/v) before data collection.

Diffraction Data Collection, Structure Solution, and Refinement {#sec3.2}
---------------------------------------------------------------

X-ray diffraction data for *Cg*-Slx1 were collected at beamline 14.1 at Berliner Elektronenspeicherring-Gesellschaft für Synchrotronstrahlung (BESSY) ([@bib30]), and data for *Cg*-Slx1-Slx4^CCD3^ were collected at beamline ID29 at European Synchrotron Radiation Facility (ESRF). Data for the phasing and refinement of *Cg*-Slx1 structure were collected at 1.280 Å wavelength. Diffraction data used for refinement of the *Cg*-Slx1-Slx4^CCD3^ structure were collected at 0.97626 Å. Diffraction data were processed and scaled with XDS ([@bib23]). The statistics of the diffraction data are summarized in [Table S1](#app3){ref-type="sec"}. Phases for *Cg*-Slx1 were determined using single-wavelength anomalous diffraction in AutoSol module in Phenix ([@bib1]), using data collected at Zn peak wavelength (1.280 Å). Phases for *Cg*-Slx1-Slx4^CCD3^ were determined by molecular replacement using Phaser-MR module in Phenix ([@bib1]). The structure of *Cg*-Slx1 was used as the starting model for molecular replacement. Interactive model building was performed in COOT ([@bib16]) and refinement with Phenix with R-free, calculated with 5% of unique reflections. The structures of *Cg*-Slx1 and *Cg*-Slx1-Slx4^CCD3^ were refined with 95.7% and 99.7% residues in the favored region of the Ramachandran plot, respectively. Structure validation was carried out using Molprobity analysis ([@bib11]). Structural analyses, including superpositions, and structural figures were prepared in Pymol (<http://www.pymol.org>). Simulated annealing composite omit maps were calculated in CNS 1.3 ([@bib8]).

Description of protein purification, oligomeric state analysis, nuclease assays, and EMSA can be found in the [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Author Contributions {#sec4}
====================
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=================
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![Nuclease Activities of *Cg*-Slx1 and *Cg*-Slx1-Slx4^CCD^\
(A) 5′-flap cleavage by *Cg*-Slx1 and the *Cg*-Slx1-Slx4^CCD^ complex. 5′-flap DNA (100 nM), spiked with negligible amounts of 5′-^32^P-labeled substrate, was incubated with increasing concentrations of *Cg*-Slx1 or *Cg*-Slx1-Slx4^CCD^ at 37°C for 15 min. Reaction products were analyzed by native PAGE and autoradiography. Red asterisk, 5′-^32^P-labeled oligonucleotide.\
(B) Substrate specificity of *Cg*-Slx1-Slx4^CCD^. The indicated DNA substrates (100 nM), spiked with trace amounts of the corresponding 5′-^32^P-labeled substrate, were incubated with 10 nM *Cg*-Slx1-Slx4^CCD^ (top) or 10 nM catalytically inactive *Cg*-Slx1^E79Q^-Slx4^CCD^ (bottom). At the indicated time points, samples were removed and reaction products were analyzed by native PAGE. Red asterisks, 5′-^32^P-labeled oligonucleotides.\
(C) Quantification of data shown in (B) by phosphorimaging. Product formation is expressed as a percentage of total radiolabeled DNA. Data are presented as the mean of at least three independent measurements ± SEM.\
See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![Overall Structure of *Cg*-Slx1\
The GIY-YIG nuclease domain is shown in purple for β strands and yellow for the rest of the sequence. The RING domain is shown in green and the connecting scaffold helix α6 in cyan. Zinc ions are shown as gray spheres. The residues forming the active site are shown as sticks and labeled. Dotted lines indicate the loop regions, which were not observed in the electron density maps. Domain boundaries are schematically shown as rectangles on top of the panels with the residue numbers given and active site residues indicated.\
See also [Table S1](#app3){ref-type="sec"} and [Figure S2](#app3){ref-type="sec"}.](gr2){#fig2}

![Slx1 Dimerization\
(A) One molecule is shown in cartoon representation and colored as in [Figure 2](#fig2){ref-type="fig"}. The other subunit is shown in cartoon and transparent surface. The residues forming the active site are shown as ball and sticks.\
(B) Close-up of the central region of the dimer interfaces.\
(C) Estimation of the MW of *Cg*-Slx1, *Cg*-Slx4^CCD^, and *Cg-*Slx1-Slx4^CCD^ using GF-MALS. The elution traces from the silica gel filtration column are shown: absorbance at 260 nm (ABS 260) as red trace, at 280 nm (ABS 280) as blue trace, and light scattering (LS) as violet trace. The measured MW throughout the peak is plotted in green (MW values are on the right axis). See also [Figure S3](#app3){ref-type="sec"}.](gr3){#fig3}

![Model of *Cg*-Slx1-DNA Interactions\
(A) A view presenting modeled DNA (cyan for the cleaved strand and blue for the non-cleaved one) interacting with *Cg*-Slx1. DNA was modeled by superimposing the catalytic cores of *Cg*-Slx1 and Eco29kI (PDB ID [3NIC](pdb:3NIC){#intref0040} \[[@bib27]\]). The color scheme of *Cg*-Slx1 is the same as in [Figure 2](#fig2){ref-type="fig"}. Amino acids predicted to interact with the DNA substrate are shown as sticks. The sphere indicates the scissile phosphate.\
(B) Cartoon of the predicted protein-DNA interactions. The site of nucleolytic cleavage is indicated with an arrow.\
(C) Cleavage of 5′-flap substrates by *Cg*-Slx1-Slx4^CCD^ mutants that contain single alanine substitutions of residues predicted to interact with DNA. The wild-type *Cg*-Slx1-Slx4^CCD^ and nuclease-inactive *Cg-*Slx1^E79Q^-Slx4^CCD^ complexes were used as positive and negative controls, respectively. 5′-flap DNA (100 nM) was spiked with negligible amounts of 5′-^32^P-labeled substrate and incubated with the indicated *Cg*-Slx1-Slx4^CCD^ complex (10 nM) at 37°C for 0, 2, 5, 10, 15, or 30 min. Reaction products were analyzed by native PAGE. Cleavage products were quantified by phosphorimaging and plotted as the percentage of total radiolabelled DNA. Data are presented as the mean of three independent experiments ± SEM.\
(D) DNA binding of *Cg*-Slx1 and *Cg*-Slx1-Slx4^CCD^ (wild-type and mutants) determined by EMSA. Protein, as indicated on the top (μM), was added to 5′-flap substrate (20 nM 5′-^33^P-labeled DNA and 105 nM cold DNA). The mixtures were resolved on 6% native TBE gels and visualization by autoradiography. The plots show the percentage of bound substrate. Data are presented as the mean of three independent experiments ± SEM.\
See also [Figure S4](#app3){ref-type="sec"}.](gr4){#fig4}

![Structure of *Cg*-Slx1-Slx4^CCD3^ Complex\
(A) Two views of the complex structure. *Cg*-Slx1 is colored as in [Figure 2](#fig2){ref-type="fig"} and *Cg*-Slx4^CCD3^ is shown in orange. The residues forming the active site are shown as ball and sticks. Dotted lines indicate the loop regions, which were not observed in the electron density maps.\
(B) Close-up view of the interactions that occur within the *Cg*-Slx1-Slx4^CCD3^ complex. Selected residues from the interface, including Gly716 from the C terminus of the last helix of CCD3, are shown as sticks.\
See also [Figure S5](#app3){ref-type="sec"}.](gr5){#fig5}
